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Non-small cell lung cancerABSTRACT
Objective: To explore the role of the abnormal expression of miRNAs in the develop-
ment process of non-small cell lung cancer and the feasibility of ultrasound microbubble-
mediated gene therapy after transfecting antisense miRNA-224 and miRNA-122a plas-
mids into non-small cell lung cancer A549 cells.
Methods: Antisense miRNA-224 and miRNA-122a plasmids were transfected into non-
small cell lung cancer A549 cells on the optimal ultrasound microbubble-mediated
condition. We set up a control group. The cell proliferation activity, apoptosis, invasion
ability were detected by MTT assay, Annexin V-PE, Transwell invasion experiment and
colony formation assay, respectively.
Results: The expression of miRNA-224 decreased and the expression of miRNA-122a
rose after the plasmids of target genes were transfected into non-small cell lung cancer
A549 cells, and there were signiﬁcant differences when compared with those of the
control group (P < 0.05). After the plasmids of target genes were transfected into A549
cells, the growth of antisense miRNA-224 and miRNA-122a were inhibited, and the
differences were signiﬁcant as compared with the control group (P < 0.05). Besides, the
inhibition of miRNA-122a group was the most signiﬁcant and there was statistically
signiﬁcant difference as compared with miRNA-224 group (t = −4.694, P = 0.009). After
the plasmids of target genes were transfected into A549 cells, the proportion of apoptotic
cells increased, the invasive cells were decreased and the clone ability reduced, and also
there was a signiﬁcant difference as compared with those of the control group (P < 0.05).
What's more, the apoptotic peak appeared in miRNA-122a group. Its invasion ability
decreased most obviously (40.25 ± 3.97/visual ﬁeld), the number of clone ability was
104.93 ± 4.87 and the inhibitory effect was the most obviously. There was statistically
signiﬁcant difference as compared with other groups (P < 0.05).
Conclusions: A549 cells transfected by ultrasound microbubble-mediated antisense
miRNA-224 and miRNA-122a plasmids possessed good transfection efﬁciency. The cell
growth, invasion and colony-forming abilities of transfected A549 cells were suppressed,
which laid a solid foundation for the gene therapy of non-small cell lung cancer.1. Introduction
Lung cancer is a kind of malignant tumor with high death rate.
Non-small cell lung cancer (NSCLC) accounts for a highproportion and also possesses high death rate [1–4]. NSCLC can be
caused by many factors, such as smoking, inheritance, chronic
lung infection and so on. However, the exact pathogenesis of
the disease still remains unknown [5]. At present, the idea that
the abnormal expressions of tumor suppressors and cancer
genes play an important role in the development process of
cancer has been approved by many scientists [6]. MicroRNA
(miRNAs) is a non-coding small RNAs which could regulate
gene expression [7]. There are researches claiming that the related
abnormal expression of miRNA can lead to the occurrence of
NSCLC. Therefore, an intensive study of that kind of miRNA isle under the CC BY-NC-ND license (http://
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NSCLC [8]. Recently, scientists have found that the expression
of miR-224 increases in tissues of liver cancer, breast cancer
and gastric cancer [9,10], while the expression of miR-122a de-
creases in tissues of liver cancer and oral cancer [11,12]. We
predicted that miR-122a and miR-224 may work certainly in the
occurrence and development of NSCLC.Microbubble ultrasound
contrast agent is a new effective widely-used delivery vector,
which can carry target genes and transfer them into cell nucleus
smoothly [13–15]. The objectives of this study was to explore the
role of the abnormal expression of miRNA-122a and miRNA-
224 on the biological characteristics of NSCLC cells after trans-
fecting antisense miRNA-122a and miRNA-224 plasmids into
non-small cell lung cancer A549 cells.
2. Materials and methods
2.1. Groups and transfection
In this study, non-small cell lung cancer A549 cells were
applied and cultured in 96-well plates with a cell density of 1000/
well. They were divided into four groups. The experimental
groups included the antisense miR-224 group in which antisense
miR-224 was transfected and the miRNA-122a group in which
miRNA-122a was transfected, while the control groups had the
control-antisense-miR-224 group in which antisense miRNA-224
plasmidwas transfected and the control-miR-122a group inwhich
miRNA-122aplasmid was transfected. Antisense miRNA-224
and miRNA-122a plasmids were mixed with microbubble sus-
pension evenly, respectively, and placed in the refrigerator at a
temperature of 4 C. After the adhesion stabilized, they were put
into the corresponding wells of the 96-well plates in accordance
with the previous grouping for ultrasonic treatment.
2.2. Methods
2.2.1. Real-time PCR
Cells were transfected according to the above grouping. A
blank control group was built. Then, the total RNA of each
group was extracted according to the directions of Trizol kits.
After that, the concentrations and purities of those RNA were
detected. cRNA was obtained according to the directions of
reverse transcriptase kits and was used as a template and
ampliﬁed by corresponding primers. Then, the expression of the
target gene was tested three times repeatedly.
2.2.2. MTT experiment
The cell suspension of A549 cells was inoculated in 96-well
plates with a number of 1000 cells and a volume of 100 mL in
each well. Three ventral oriﬁces and four 96-well plates were
inoculated and cultured in an incubator. After 24 h, cells were
transfected according to the above grouping. After transfected
for 1, 2, 3 and 4 days, 20 mL of MTT solution was added into
each well, respectively. After that, the culture solution was
discarded after culturing 4 h continuously and 150 mL of DMSO
dissolved crystal was added. Ten minutes later, the absorbance
value was test for three times and the data were analyzed.
2.2.3. Annexin V-PE experiment
Cells were transfected according to the corresponding
groups. Then, cells were collected after digested by pancreatin(no EDTA) and washed by PBS. Binding Buffer with 7-AAD
was added into the collected cells. After reacting for 5–
15 min, 450 mL Binding Buffer was added sequentially and 1 mL
of Annexin V-PE was added. After reacting for 5–15 min, ﬂow
cytometer was employed for detection which was repeated for
three times.
2.2.4. Transwell assay
A549 cells were grouped into the antisense miR-224 group,
miR-122a group, control-antisense miR-224 group and control-
miR-122a group. A number of 100 mL cell suspension extracted
from each group with a density of 5 × 105/mL was added into
the invasion chamber. And then they were cultured in an incu-
bator for one day and counted for three times.
2.2.5. Soft agar clone formation assay
Cells were transfected according to the previous grouping.
An underlying agar was made in 6-well plates. Next, 100 mL of
cell suspension with a concentration of 10000/mL was added
into every 1 mL top agar and then paved on the underlying agar
carefully. They were placed in an incubator for 10 days after
solidiﬁcation. After that, the number of cell colonies was
calculated for three times.
2.3. Statistical methods
SPSS19.0 was used for statistical analysis. The cell prolif-
eration activity, apoptosis, invasion ability of miRNA-224 and
miENA-122a in A549 cells transfected by miR-122a group and
antisense miR-224 group were detected by t-test. Differences
were statistically signiﬁcant when P < 0.05.
3. Results
3.1. The expressions of miRNA-224 and miRNA-122a of
A549 after transfected
It was discovered by real-time PCR detection that the
expression of miRNA-224 of A549 cells decreased signiﬁcantly
after transfected antisense miRNA-224 and miRNA-122a plas-
mids, and there were signiﬁcant differences as compared with
those of the control group (t = −4.634, P = 0.010); while the
expression of miRNA-122a increased obviously and the differ-
ences were statistical signiﬁcant (t = 6.448, P = 0.003) (Table 1).
3.2. The cell proliferation detected by MTT experiment
Compared with the relative control group, the proliferation of
A549 cells reduced distinctly after transfecting antisense miR-
224 and miR-122a plasmids. Moreover, the proliferation of
A549 cells transfected miR-122a plasmids slowed down most
obviously. The differences from the ﬁrst day to the fourth were
statistically signiﬁcant (P < 0.05). Besides, on the fourth day of
transfection, the proliferation rate of A549 which transfected
miR-122a plasmids was slower than that of A549 transfected
antisense miR-224 plasmids. The differences were statistical
signiﬁcant (t = −4.694, P = 0.009). After transfecting antisense
miR-224 plasmids, the proliferation rates of the ﬁrst two days
remained no distinct differences as compared to the control
group. However, the proliferation rates of the third and fourth
days were slower evidently than those of the control group. The
Table 1
The expressions level, apoptosis, number of invasion cells and change of the ability of cell clone formation of A549.
Group Expression level Apoptosis of A549 cells (%) Number of invasion cells of
A549
Change ability of cell clone
formation
miRNA-224 miRNA-122a miRNA-224 miRNA-122a miRNA-224 miRNA-122a miRNA-224 miRNA-122a
Experiment
group
0.331 ± 0.102 2.401 ± 0.201 8.89 ± 0.33 10.99 ± 0.28 79.34 ± 3.99 40.25 ± 3.97 139.21 ± 8.99 104.93 ± 4.87
Control
group
0.934 ± 0.201 0.991 ± 0.321 1.89 ± 0.10 1.90 ± 0.15 140.21 ± 3.55 139.31 ± 4.13 287.24 ± 8.38 299.78 ± 5.13
t −4.634 6.448 35.162 49.565 −19.741 −29.951 −20.862 −47.712
P 0.010 0.003 0.000 0.000 0.000 0.000 0.000 0.000
Note: The expressions level was expressions of miRNA-224 and miRNA-122a of A549; apoptosis of A549 cells was apoptosis after transfecting
plasmids (%), number of invasion cells of A549 cells was detected by Transwell assay (number/vision), the change of the ability of cell clone for-
mation of A549 was detected after transfecting target gene plasmids.
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P = 0.017, t = −4.146, P = 0.014) (Table 2).
3.3. Detection of the change of cell apoptosis by Annexin
V-PE
The cell apoptosis of A549 cell was detected by Annexin V-
PE. The results showed that the apoptosis rates of cells trans-
fecting antisense miR-224 and miR-122a plasmids increased
signiﬁcantly. The cell apoptosis rate of the antisense miR-224
group increased obviously as compared with that of the
control-antisense miR-224 group. The differences had statistical
signiﬁcances (t = 35.162, P = 0.000). The cell apoptosis rate of
the antisense miR-122a group also increased obviously as
compared with that of the control-miR-122a group. The differ-
ences showed statistical signiﬁcances (t = 49.565, P = 0.000). In
addition, the cell apoptosis rate of the miR-122a group was
higher than that of the antisense miR-224 group and the dif-
ferences were statistically signiﬁcant (t = 8.404, P = 0.001)
(Table 1).
3.4. The detection of the invasion ability of A549 cells by
Transwell assay
The number of cells of every vision was observed by a mi-
croscope. The results showed that the invasion ability of A549
cells reduced signiﬁcantly after transfecting target gene plas-
mids, and the differences remained statistically signiﬁcant
(P < 0.05). Besides, the invasion inhibitory ability of A540 cells
which transfected miRNA-122a was better than that of the
antisense miR-224 group, and the differences were also statis-
tically signiﬁcant (t = −9.259, P = 0.001) (Table 1).
3.5. The change of the ability of cell clone formation
The results of the colony-forming unit assays revealed that
the clone formation ability of D549 declined after transfectingTable 2
The cell proliferation of A549 after transfected plasmids.
The 1st day The
Antisense miR-224 0.239 ± 0.029 0.549
miR-122a 0.229 ± 0.021# 0.421
control-antisense-miR-224 0.284 ± 0.009 0.632
control-miR-122a 0.291 ± 0.011 0.662
Compared with the control-antisense-miR-224 group, *P < 0.05; compared
antisense miR-224 group, 8P < 0.05.target gene plasmids as compared with the control group, and
the differences had statistical signiﬁcance (P < 0.05). Besides,
the inhibitory effect of A549 cells group on its clone formation
transfecting miRNA-122a was better than that of the antisense
miR-224 group. The differences were also statistically signiﬁ-
cant (t = −5.807, P = 0.004) (Table 1).4. Discussion
NSCLC is kind of tumor with a high grade of malignancy
which severely threatens human health. Surgery, radiotherapy
and chemotherapy do not work effectively, so a new treatment
plan is needed to be developed [16–19]. At present, gene therapy
has raise passions and concerns, which might provide a new way
for the treatment of the disease. In the occurrence and
development of tumor, miRNA, a kind of small endogenous,
plays an important role [20,21]. The expression quantity of
miRNA can be detected by many ways. Among them, real-
time RT-PCR is used most commonly because of its excellent
speciﬁcity, sensitivity and accuracy [22–24]. However, owing to
the lack of gene vectors, researches on miRNA become
difﬁcult. Recently, researches have shown that ultrasound
microbubble with target gene injected into bodies for
ultrasound irradiation could lead to favorable transfection
effect [25,26]. The main objective of this study was to explore
the role of the abnormal expression of miRNA-122a and
miRNA-224 on the biological characteristics of NSCLC A549
cells transfecting miRNA-122a and antisense miRNA-224
plasmids.
MiRNA could regulate many expressions of mRNA, which is
a key substance of the upstream of the signal pathways in cells.
Hence, the research on miRNA was of great importance to the
study of the disease [27]. The results of this study showed that the
expression level of A549 cells transfecting antisense miR-224
decreased signiﬁcantly and the expression level of miR-122a
in non-small cell lung cancer A549 cells increased obviously
as compared with the control group. It is indicated that2nd day The 3rd day The 4th day
± 0.059 0.880 ± 0.038* 0.991 ± 0.035*
± 0.025# 0.771 ± 0.065# 0.849 ± 0.039#8
± 0.015 1.056 ± 0.068 1.200 ± 0.080
± 0.031 1.060 ± 0.070 1.155 ± 0.146
with the control-miR-122a group, #P < 0.05; and compared with the
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fect, which could be used for follow-up studies.
In this study, MTT assay was employed to detect the pro-
liferation condition of non-small cell lung cancer A549 cells.
The results showed that there were distinct differences of the
proliferation conditions between the experiment group and
control group. The proliferation of A549 of the experiment
group was inhibited evidently. In previous studies, mir-244 has
over-expressed in some tumors and improved proliferation.
However, miR-122a did the opposite [10,11]. Therefore, when
plasmids of antisense miR-224 and over-expressed miR-122a
were transfected, the proliferation of A549 was inhibited
effectively.
Annexin V-PE experiment was used to determine the
apoptosis of non-small cell lung cancer A549 cells. The results
showed that the apoptosis rate of the experiment group was
raised signiﬁcantly as compared with that of the control group.
Besides, the apoptosis rate of the miR-122a group was more
than 10%, which might be related to the wonderful effect of the
ultrasound microbubble-mediated-transfection and its biological
function. There were researches claiming that miR-122a could
promote the apoptosis of hepatoma cells by regulating the ex-
pressions of genes such as Bcl-2, Mcl-1. Plasmids transfected in
non-small cell lung cancer cells played a similar role in the
process [28–30].
The results of Transwell assay revealed that after transfecting
the target gene, the invasion ability of the experiment group
declined signiﬁcantly as compared to the control group. After
transfected antisense miR-224 and miR-122a plasmids, the
expression of miR-224 of A549 cells reduced and the expression
of miR-122a increased. They might work on the direct target
gene PTEN to increase the expression quantity of PTEN and
weaken the invasion ability of A549 cells [31].
Results of soft agar clone formation assay declared that the
clone formation capacity of the expression group reduced
signiﬁcantly and cells transfecting miR-122a showed the best
clone formation capacity. This may be because the decrease of
the expression of miR-224 and the increase of the expression of
miR-122a caused the change of the expressions of substances
such as HIF-1a, CDKNI B/p27, CDKNI A/p21 and so on,
which, as a result, decreased its clone formation capacity.
To sum up, in non-small cell lung cancer A549 cells, the
proliferation, invasion ability and clone formation capacity of
A549 cells were inhibited obviously after transfecting antisense
miR-224 and miR-122a plasmids by microbubble ultrasound
contrast agent. In addition, the number of apoptosis cells
increased distinctly. This analysis of the biological characteris-
tics of non-small cell lung cancer A549 cells by miRNAs pro-
vided a new way for the gene therapy of NSCLC.
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